Posts in Portfolio News
Canopy Rivers Portfolio Company Licensed by Health Canada, Triggering Long-Term Cash Flow Stream

Canopy Rivers Inc. (“Canopy Rivers” or the “Company”) (TSXV: RIV) congratulates Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) (“Canopy Growth”) and its portfolio company, Spot Therapeutics Inc. (“Spot”), on receiving a cultivation license from Health Canada for its Fredericton-based production and distribution facility. 

Read More
Canopy Rivers Portfolio Company Headset Enters Into Alliance With Global Data Analytics Giant Nielsen

Canopy Rivers Inc. (the “Company” or “Canopy Rivers”) (TSXV: RIV) congratulates its portfolio company Headset, Inc. (“Headset”) on the formation of its landmark strategic alliance with Nielsen Holdings plc (“Nielsen”) (NYSE: NLSN). Yesterday, Nielsen and Headset together announced an alliance that will provide U.S. cannabis market data and analytics to consumer packaged goods (CPG) companies monitoring the cannabis space.

Read More
Canopy Rivers Provides Update on Milestones Achieved by Its Italian Hemp-Focused Investment

anopy Rivers Inc. (the “Company” or “Canopy Rivers”) (TSXV: RIV) is pleased to provide an update on the operations of Canapar SrL (“Canapar), an Italian-based hemp production and processing platform and subsidiary of portfolio company, Canapar Corp. Yesterday evening, in Ragusa, Sicily, Canapar hosted a ribbon cutting ceremony for its new cannabidiol (“CBD”) extraction and processing facility.

Read More
Canopy Rivers Announces $80 Million Bank Debt Facility at PharmHouse

Canopy Rivers Inc. (“Canopy Rivers” or the “Company”) (TSXV: RIV) today announced that its 49%-owned joint venture PharmHouse Inc. (“PharmHouse”) has entered into a syndicated credit facility (the “Credit Facility”) with the Bank of Montreal (“BMO”), as agent and lead lender, and with Canadian Imperial Bank of Commerce and Concentra Bank as lenders (together with BMO, the “Lenders”).

Read More
Canopy Rivers Portfolio Company TerrAscend Gains Traction in New Jersey Medical Cannabis Market

Canopy Rivers Inc. (“Canopy Rivers” or the “Company”) (TSXV: RIV) today provided an update that an entity controlled by its portfolio company TerrAscend Corp. (“TerrAscend”) (CSE: TER; OTCQX: TRSSF), NETA NJ LLC (“NETA”), has been selected by the State of New Jersey Department of Health to apply for final approval to operate a vertically integrated Alternative Treatment Center (ATC), which would permit it to cultivate, process and sell medical cannabis in the state.

Read More
Canopy Rivers Portfolio Company Radicle Receives Licence From Health Canada to Commence Sales of Premium Craft Cultivated Product

Canopy Rivers Inc. (“Canopy Rivers” or the “Company”) (TSXV:RIV) congratulates its portfolio company, Radicle Medical Marijuana Inc. (“Radicle”), on receiving its production and sales licence from Health Canada. The licence will allow Radicle to supply and sell finished cannabis products for both the medical and adult-use market in Canada. 

Read More